Haisco Pharmaceutical Group Co Ltd banner

Haisco Pharmaceutical Group Co Ltd
SZSE:002653

Watchlist Manager
Haisco Pharmaceutical Group Co Ltd Logo
Haisco Pharmaceutical Group Co Ltd
SZSE:002653
Watchlist
Price: 47.39 CNY -1.27% Market Closed
Market Cap: ¥53.1B

Income Statement

Earnings Waterfall
Haisco Pharmaceutical Group Co Ltd

Income Statement
Haisco Pharmaceutical Group Co Ltd

Rotate your device to view
Income Statement
Currency: CNY
Jun-2011 Sep-2011 Dec-2011 Mar-2012 Jun-2012 Sep-2012 Dec-2012 Mar-2013 Jun-2013 Sep-2013 Dec-2013 Mar-2014 Jun-2014 Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025 Sep-2025
Revenue
Interest Expense
0
0
0
0
0
0
1
0
0
0
3
0
0
0
12
0
0
0
15
0
0
0
19
0
0
8
25
0
0
10
20
11
18
22
24
25
26
27
27
25
22
22
27
35
39
46
51
51
54
48
42
39
37
39
38
37
0
0
Revenue
590
N/A
589
0%
604
+3%
637
+5%
671
+5%
753
+12%
802
+7%
875
+9%
934
+7%
998
+7%
992
-1%
1 031
+4%
1 067
+3%
1 110
+4%
1 211
+9%
1 226
+1%
1 233
+1%
1 179
-4%
1 213
+3%
1 147
-5%
1 327
+16%
1 342
+1%
1 436
+7%
1 535
+7%
1 607
+5%
1 806
+12%
1 856
+3%
2 061
+11%
2 209
+7%
2 625
+19%
3 427
+31%
3 788
+11%
4 105
+8%
4 329
+5%
3 937
-9%
3 687
-6%
3 520
-5%
3 326
-6%
3 330
+0%
3 469
+4%
3 154
-9%
2 866
-9%
2 773
-3%
2 607
-6%
2 744
+5%
2 959
+8%
3 015
+2%
3 077
+2%
3 138
+2%
3 302
+5%
3 355
+2%
3 484
+4%
3 672
+5%
3 722
+1%
3 721
0%
3 861
+4%
4 036
+5%
4 270
+6%
Gross Profit
Cost of Revenue
(210)
(209)
(209)
(221)
(211)
(225)
(204)
(228)
(243)
(271)
(269)
(304)
(319)
(327)
(367)
(381)
(403)
(401)
(401)
(399)
(434)
(425)
(372)
(400)
(372)
(531)
(659)
(798)
(976)
(1 059)
(1 494)
(1 720)
(1 792)
(1 876)
(1 348)
(1 245)
(1 144)
(1 027)
(1 068)
(1 147)
(1 117)
(1 076)
(947)
(918)
(909)
(956)
(925)
(955)
(965)
(981)
(971)
(1 090)
(1 106)
(1 091)
(1 062)
(1 140)
(1 181)
(1 222)
Gross Profit
380
N/A
380
+0%
396
+4%
416
+5%
460
+10%
527
+15%
598
+13%
647
+8%
691
+7%
727
+5%
723
-1%
727
+1%
748
+3%
784
+5%
844
+8%
845
+0%
831
-2%
778
-6%
811
+4%
748
-8%
893
+19%
918
+3%
1 064
+16%
1 134
+7%
1 234
+9%
1 275
+3%
1 197
-6%
1 263
+5%
1 233
-2%
1 566
+27%
1 933
+23%
2 068
+7%
2 313
+12%
2 453
+6%
2 589
+6%
2 442
-6%
2 376
-3%
2 300
-3%
2 262
-2%
2 322
+3%
2 037
-12%
1 790
-12%
1 826
+2%
1 689
-8%
1 836
+9%
2 003
+9%
2 090
+4%
2 122
+2%
2 173
+2%
2 321
+7%
2 384
+3%
2 394
+0%
2 566
+7%
2 631
+3%
2 660
+1%
2 721
+2%
2 854
+5%
3 048
+7%
Operating Income
Operating Expenses
(104)
(113)
(115)
(133)
(169)
(202)
(277)
(295)
(308)
(320)
(307)
(302)
(329)
(366)
(457)
(435)
(426)
(436)
(473)
(473)
(598)
(612)
(803)
(882)
(1 010)
(1 049)
(1 089)
(993)
(986)
(1 229)
(1 591)
(1 769)
(1 888)
(2 022)
(2 050)
(1 809)
(1 839)
(1 728)
(1 822)
(1 961)
(1 772)
(1 759)
(1 713)
(1 605)
(1 718)
(1 804)
(1 911)
(1 935)
(1 983)
(2 013)
(1 983)
(1 900)
(2 032)
(2 125)
(2 286)
(2 411)
(2 519)
(2 661)
Selling, General & Administrative
(106)
(114)
(114)
(132)
(167)
(201)
(203)
(295)
(309)
(320)
(230)
(302)
(329)
(366)
(309)
(434)
(425)
(435)
(291)
(470)
(587)
(601)
(641)
(878)
(1 024)
(1 066)
(931)
(1 113)
(1 100)
(1 389)
(1 523)
(1 666)
(1 844)
(1 890)
(1 978)
(1 880)
(1 794)
(1 713)
(1 570)
(1 629)
(1 446)
(1 358)
(1 267)
(1 253)
(1 320)
(1 400)
(1 397)
(1 507)
(1 534)
(1 583)
(1 532)
(1 567)
(1 638)
(1 646)
(1 765)
(1 820)
(1 911)
(2 010)
Research & Development
0
0
0
0
0
0
(63)
0
0
0
(60)
0
0
0
(126)
0
0
0
(158)
0
0
0
(127)
0
0
(43)
(119)
0
0
(63)
(194)
(181)
(229)
(236)
(228)
(244)
(259)
(317)
(393)
(447)
(486)
(471)
(422)
(428)
(420)
(428)
(439)
(453)
(477)
(512)
(501)
(509)
(522)
(553)
(606)
(684)
(751)
(789)
Depreciation & Amortization
0
0
0
0
0
0
(11)
0
0
0
(17)
0
0
0
(22)
0
0
0
(24)
0
0
0
(35)
0
0
0
(38)
0
0
0
(53)
0
0
0
(66)
0
0
0
(73)
0
0
0
(99)
0
0
0
(111)
0
0
0
(56)
0
0
0
(69)
0
0
0
Other Operating Expenses
2
0
(1)
(1)
(2)
0
(0)
0
1
(0)
(0)
(0)
(0)
0
(0)
(1)
(1)
(1)
(0)
(3)
(11)
(11)
(0)
(5)
13
60
(1)
120
114
223
178
78
184
105
222
316
214
302
214
114
161
69
75
76
22
24
35
25
28
83
106
175
128
74
154
93
143
138
Operating Income
276
N/A
268
-3%
281
+5%
284
+1%
291
+3%
325
+12%
321
-1%
351
+10%
383
+9%
407
+6%
417
+2%
425
+2%
419
-1%
418
0%
387
-7%
410
+6%
405
-1%
342
-15%
338
-1%
275
-19%
295
+7%
305
+3%
261
-15%
253
-3%
224
-11%
226
+1%
109
-52%
270
+149%
247
-8%
337
+37%
341
+1%
299
-12%
425
+42%
432
+2%
540
+25%
633
+17%
538
-15%
572
+6%
440
-23%
361
-18%
266
-26%
30
-89%
113
+277%
84
-26%
118
+40%
199
+69%
179
-10%
187
+4%
190
+2%
309
+63%
401
+30%
493
+23%
534
+8%
506
-5%
374
-26%
310
-17%
335
+8%
388
+16%
Pre-Tax Income
Interest Income Expense
3
5
7
10
16
24
28
33
35
35
45
54
58
69
68
68
72
68
67
65
64
64
71
70
63
53
40
29
22
21
12
12
13
8
7
(10)
(13)
(14)
(0)
671
677
669
1
(13)
(31)
(41)
(78)
179
177
173
(85)
(108)
(100)
85
(61)
133
129
(31)
Non-Reccuring Items
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
118
0
0
0
(30)
0
0
0
0
(0)
(1)
(6)
259
1
1
6
398
(0)
(0)
0
263
0
0
(1)
(4)
(0)
25
25
194
31
6
6
Gain/Loss on Disposition of Assets
0
0
(1)
0
0
0
(3)
0
0
0
(3)
0
0
0
(0)
(0)
(0)
(1)
(1)
(0)
0
0
0
0
(0)
0
0
0
0
0
0
0
0
0
(0)
0
0
0
(6)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Other Income
87
90
83
113
124
108
135
87
101
102
110
94
103
91
50
51
10
12
11
11
85
83
152
157
76
73
(8)
(15)
(8)
(10)
(1)
1
1
3
(0)
(3)
(5)
(7)
(4)
(9)
(8)
(12)
(1)
(2)
1
6
3
2
(2)
(3)
(9)
(12)
(18)
(29)
(44)
(49)
(57)
(43)
Pre-Tax Income
366
N/A
362
-1%
369
+2%
406
+10%
431
+6%
457
+6%
480
+5%
471
-2%
519
+10%
543
+5%
569
+5%
572
+1%
579
+1%
578
0%
505
-13%
529
+5%
487
-8%
422
-13%
415
-2%
350
-16%
444
+27%
453
+2%
484
+7%
480
-1%
362
-25%
352
-3%
259
-26%
284
+10%
261
-8%
348
+33%
323
-7%
312
-3%
440
+41%
443
+1%
546
+23%
620
+13%
519
-16%
545
+5%
690
+26%
1 024
+48%
936
-9%
693
-26%
511
-26%
68
-87%
87
+28%
163
+87%
367
+125%
368
+0%
365
-1%
478
+31%
303
-37%
373
+23%
441
+18%
587
+33%
463
-21%
425
-8%
413
-3%
320
-23%
Net Income
Tax Provision
(57)
(57)
(57)
(63)
(54)
(49)
(37)
(28)
(38)
(41)
(50)
(53)
(55)
(58)
(54)
(60)
(53)
(50)
(43)
(35)
(49)
(47)
(47)
(43)
(29)
(30)
(30)
(42)
(29)
(24)
(6)
(2)
(29)
(44)
(72)
(74)
(64)
(72)
(88)
(85)
(57)
(22)
7
20
13
15
25
26
28
13
(7)
(15)
(54)
(41)
3
(3)
19
(10)
Income from Continuing Operations
309
305
312
343
377
407
443
443
481
502
519
520
524
520
451
469
434
372
372
315
395
406
436
437
333
322
229
242
232
324
318
309
411
399
475
546
455
473
601
939
879
671
518
88
100
178
392
393
393
490
296
358
387
546
466
422
432
309
Income to Minority Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7
7
8
13
8
12
15
13
16
14
12
14
19
26
33
40
35
(143)
(150)
(162)
(173)
(4)
(5)
(5)
(115)
(114)
(111)
(116)
(0)
0
(2)
(70)
(71)
(72)
(72)
(1)
Net Income (Common)
309
N/A
305
-1%
312
+2%
343
+10%
377
+10%
407
+8%
443
+9%
443
0%
481
+9%
502
+4%
519
+3%
520
+0%
524
+1%
520
-1%
451
-13%
469
+4%
434
-8%
372
-14%
372
+0%
315
-15%
395
+26%
406
+3%
443
+9%
444
+0%
341
-23%
335
-2%
238
-29%
254
+7%
247
-3%
337
+36%
333
-1%
323
-3%
423
+31%
413
-2%
494
+20%
573
+16%
488
-15%
513
+5%
637
+24%
796
+25%
728
-8%
509
-30%
345
-32%
84
-76%
95
+13%
173
+83%
277
+60%
280
+1%
282
+1%
375
+33%
295
-21%
358
+21%
385
+7%
476
+24%
395
-17%
350
-11%
360
+3%
309
-14%
EPS (Diluted)
0.29
N/A
0.29
N/A
0.29
N/A
0.32
+10%
0.35
+9%
0.38
+9%
0.41
+8%
0.41
N/A
0.45
+10%
0.47
+4%
0.48
+2%
0.49
+2%
0.49
N/A
0.49
N/A
0.42
-14%
0.44
+5%
0.41
-7%
0.35
-15%
0.35
N/A
0.3
-14%
0.37
+23%
0.38
+3%
0.41
+8%
0.41
N/A
0.32
-22%
0.31
-3%
0.22
-29%
0.24
+9%
0.23
-4%
0.32
+39%
0.31
-3%
0.31
N/A
0.4
+29%
0.39
-3%
0.46
+18%
0.53
+15%
0.45
-15%
0.5
+11%
0.59
+18%
0.74
+25%
0.68
-8%
0.49
-28%
0.32
-35%
0.07
-78%
0.08
+14%
0.16
+100%
0.26
+63%
0.29
+12%
0.22
-24%
0.34
+55%
0.27
-21%
0.32
+19%
0.35
+9%
0.43
+23%
0.35
-19%
0.31
-11%
0.32
+3%
0.28
-12%
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett